1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPL CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA PNISR CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA LUC7L2 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA MAD2L2 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA ARFGEF2 CTRPv2 pan-cancer AAC -0.17 3e-07
mRNA AHNAK CTRPv2 pan-cancer AAC -0.18 3e-07
mRNA BRSK1 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA EP400 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA DPYSL5 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA SULT4A1 CTRPv2 pan-cancer AAC 0.2 3e-07
Download CSV